ARMCX1

Across TCGA pan-cancer cohorts, ARMCX1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated ARMCX1 data layer compared with 22 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ARMCX1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ARMCX1 expression acts as an unfavorable survival marker.

UCEC, OV, and LUAD are the cancer types where ARMCX1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	0.638	1.000	.014	34	view →
OV	DFS	Quartile	All	0.601	0.923	.030	24	view →
LUAD	DFS	Quartile	II,III,IV	0.738	1.000	<.001	21	view →
LSCC	OS	Tertile	II,III,IV	0.659	0.914	.009	12	view →
CCRCC	DFS	Tertile	II,III,IV	0.325	0.761	.023	8	view →
PDAC	DFS	Tertile	All	0.731	0.836	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

ARMCX1–UCEC (OS)

Open the UCEC breakdown →